Planta Med 2021; 87(15): 1267
DOI: 10.1055/s-0041-1736838
Abstracts
8. Poster Contributions
8.3 Antiinfectives and Epidemiology

Comparison of epidemiological data on functional GI diseases under an herbal therapy from non-interventional studies in the US and Germany

J Möller
1   R&D, Phytomedicines Supply and Development Center, Bayer Consumer Health, Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany
,
O Kelber
1   R&D, Phytomedicines Supply and Development Center, Bayer Consumer Health, Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany
2   Kooperation Phytopharmaka GbR, Bonn, Germany
,
E Raskopf
3   Institute for Medical Statistics and Bioinformatics, University Clinics Cologne, Cologne, Germany
4   ClinCompetence, Cologne, Germany
,
K Nieber
2   Kooperation Phytopharmaka GbR, Bonn, Germany
5   Institute of Pharmacy, University of Leipzig, Leipzig, Germany
,
O Grundmann
6   College of Pharmacy, Department of Medicinal Chemistry, University of Florida, FL, USA
7   College of Nursing, Department of Biobehavioral Nursing Science, University of Florida, FL, USA
› Institutsangaben
JM has been intern, OK is employee of Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany. KN and ER received fees from Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany.
› Weitere Informationen
Auch verfügbar aufeRef
 

The comparison of epidemiological data from different countries can help to improve the understanding of patient's needs and of therapeutic approaches globally. In two recent non-interventional studies (NIS), one from the US and the other from Germany [1] [2] [3], data from patients with functional GI symptoms using an herbal medicine [4] [5] have been collected. The US study was conducted by Grundmann et al. by an internet questionnaire. The study from Germany was a NIS in patients who used natural products (PhytoVIS) and carried out through interviews in pharmacies and doctor's offices. Original data on users of the same natural product, STW 5, were selected from both studies and evaluated using descriptive statistics.

The number of patients meeting the inclusion criteria in the US study was 50, in German (DE) 1515. 88% of the US resp. 70% of DE participants were female. Dyspepsia-like symptoms were the largest group in both studies, while IBS could be assigned to 15.6% resp. 4.0% of patients. 50.7% resp. 63.1% rated the treatment very effective, 24.5% resp. 32.4% moderate, 5.9% resp. 5.6% not effective, and 21.7% resp. 0% did not know.

There are, accordingly, considerable similarities, e. g., in the predominance of female patients and the rating of the treatment effect. Overall, these studies turn out to be a valuable source of data on the use of an herbal treatment and for assessing differences and similarities between the patient populations in the US and Germany.

Many thanks to Annika Lindner for the analysis of the data.

The study was supported by Kooperation Phytopharmaka, Bonn, Germany.



Publikationsverlauf

Artikel online veröffentlicht:
13. Dezember 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany